Literature DB >> 9699810

Clinical sepsis and death in a newborn nursery associated with contaminated parenteral medications--Brazil, 1996.

.   

Abstract

In October 1996, a total of 35 newborn infants died in a 26-bed nursery of a 200-bed hospital in Roraima, Brazil; these deaths represented a significant increase over the baseline mortality rate in the nursery (6.0 versus 1.7 per 100 live births; p<0.01). Twenty of the deaths were attributed to sepsis. Fatal episodes of sepsis began 24-72 hours after birth. Although an investigation by the Roraima Health Department resulted in an improvement of infection control, increased episodes of fever and clinical sepsis persisted. As a result, in November 1996, the Secretary of Health of Roraima, Brazil Ministry of Health, requested that CDC assist in the investigation. This report summarizes this investigation, which implicated locally produced intravenous (IV) solutions as the source of the outbreak and underscores the need to assure proper quality control of parenteral medications and the importance of nosocomial infection surveillance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9699810

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  3 in total

1.  Optimal media for use in air sampling to detect cultivable bacteria and fungi in the pharmacy.

Authors:  Alice S Weissfeld; Riya Augustin Joseph; Theresa V Le; Ernest A Trevino; M Frances Schaeffer; Paula H Vance
Journal:  J Clin Microbiol       Date:  2013-07-31       Impact factor: 5.948

Review 2.  Straight from the headlines: what is going on in compounding pharmacies, and how can clinical microbiologists help?

Authors:  Alice S Weissfeld
Journal:  J Clin Microbiol       Date:  2013-06-19       Impact factor: 5.948

3.  Should we use closed or open infusion containers for prevention of bloodstream infections?

Authors:  Manuel S Rangel-Frausto; Francisco Higuera-Ramirez; Jose Martinez-Soto; Victor D Rosenthal
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-02-02       Impact factor: 3.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.